Skip to main content
main-content

Zeitschrift

Medical Oncology

Medical Oncology 1/2011

Sonderheft 1/2011

Inhaltsverzeichnis ( 107 Artikel )

01.12.2011 | PUBLISHER NOTE | Sonderheft 1/2011

Note from publisher

01.12.2011 | Original Paper | Sonderheft 1/2011

Gemcitabine and cisplatin salvage regimen in heavily pretreated metastatic breast cancer: a Brazilian experience

01.12.2011 | Original paper | Sonderheft 1/2011

Predictors of mammography use in older women with disability: the patients’ perspectives

01.12.2011 | Original Paper | Sonderheft 1/2011

Significance of vascular endothelial growth factor, interleukin-18 and nitric oxide in patients with breast cancer: correlation with carbohydrate antigen 15.3

01.12.2011 | Original Paper | Sonderheft 1/2011

Whether drainage should be used after surgery for breast cancer? A systematic review of randomized controlled trials

01.12.2011 | Original Paper | Sonderheft 1/2011

Evaluation of ER, PgR, HER-2, Ki-67, cyclin D1, and nm23-H1 as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer

01.12.2011 | Original Paper | Sonderheft 1/2011

Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group

01.12.2011 | Original Paper | Sonderheft 1/2011

ER, PgR, HER-2, Ki-67, topoisomerase IIα, and nm23-H1 proteins expression as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer

01.12.2011 | Sonderheft 1/2011

Bcl-2 expression and triple negative profile in breast carcinoma

01.12.2011 | Sonderheft 1/2011

Phyllodes tumor of the breast

01.12.2011 | Original Paper | Sonderheft 1/2011

Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage II and III breast cancer

01.12.2011 | Original Paper | Sonderheft 1/2011

Health-related quality of life after chemotherapy cycle in breast cancer in Iran

01.12.2011 | Original Paper | Sonderheft 1/2011

Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer

01.12.2011 | Original Paper | Sonderheft 1/2011

Cardiac risk associated with the receipt of anthracycline and trastuzumab in a large nationwide cohort of older women with breast cancer, 1998–2005

01.12.2011 | Original Paper | Sonderheft 1/2011

Effects of SMYD3 over-expression on cell cycle acceleration and cell proliferation in MDA-MB-231 human breast cancer cells

01.12.2011 | Original paper | Sonderheft 1/2011

Oxymatrine diminishes the side population and inhibits the expression of β-catenin in MCF-7 breast cancer cells

01.12.2011 | Orginal Paper | Sonderheft 1/2011

Significance of survivin and Bcl-2 homologous antagonist/killer mRNA in detection of bone metastasis in patients with breast cancer

01.12.2011 | Original Paper | Sonderheft 1/2011

Weekly ixabepilone administration in heavily pretreated metastatic breast cancer patients

01.12.2011 | Original Paper | Sonderheft 1/2011

Significance of epidermal growth factor receptor expression in breast cancer

01.12.2011 | Original Paper | Sonderheft 1/2011

CK5/6, EGFR, Ki-67, cyclin D1, and nm23-H1 protein expressions as predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer patients

01.12.2011 | Original Paper | Sonderheft 1/2011

MCF-7/ADR cells (re-designated NCI/ADR-RES) are not derived from MCF-7 breast cancer cells: a loss for breast cancer multidrug-resistant research

01.12.2011 | Original paper | Sonderheft 1/2011

A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancer

01.12.2011 | Original paper | Sonderheft 1/2011

Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction

01.12.2011 | Original Paper | Sonderheft 1/2011

Neurofibromatosis type 1-associated wild-type gastrointestinal stromal tumor treated with anti-IGF-1R monoclonal antibody

01.12.2011 | Original Paper | Sonderheft 1/2011

Complete response after sorafenib therapy for hepatocellular carcinoma in an HIV-HBV co infected patient: Possible synergy with HAART ? A case report

01.12.2011 | Review Article | Sonderheft 1/2011

High-grade neuroendocrine carcinoma of the colon, long-term survival in advanced disease

01.12.2011 | Original paper | Sonderheft 1/2011

The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma

01.12.2011 | Original Paper | Sonderheft 1/2011

Prognostic factors and outcome of resected patients with gastrointestinal stromal tumors of small intestine

01.12.2011 | Original Paper | Sonderheft 1/2011

Down-regulation of miR-212 expression by DNA hypermethylation in human gastric cancer cells

01.12.2011 | Original Paper | Sonderheft 1/2011

Overexpression of SGLT1 and EGFR in colorectal cancer showing a correlation with the prognosis

01.12.2011 | original paper | Sonderheft 1/2011

Gastrointestinal stromal tumor of the rectum with bone and liver metastasis: a case study

01.12.2011 | OriginalPaper | Sonderheft 1/2011

MUC2 and MUC6 apomucins expression in human gastric neoplasm: an immunohistochemical analysis

01.12.2011 | Original Paper | Sonderheft 1/2011

Clinical significance of microsatellite instability for stage II or III colorectal cancer following adjuvant therapy with doxifluridine

01.12.2011 | Original paper | Sonderheft 1/2011

CIDE-3 interacts with lipopolysaccharide-induced tumor necrosis factor, and overexpression increases apoptosis in hepatocellular carcinoma

01.12.2011 | Original paper | Sonderheft 1/2011

Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma

01.12.2011 | Original Paper | Sonderheft 1/2011

Decreased expression of p39 is associated with a poor prognosis in human hepatocellular carcinoma

01.12.2011 | Original Paper | Sonderheft 1/2011

Impressive efficacy of sorafenib in a patient with an hepatocellular carcinoma and a portal vein thrombosis associated with a metastatic ENT cancer

01.12.2011 | Case Report | Sonderheft 1/2011

Primary gastric Hodgkin lymphoma and metachronous early gastric carcinoma: a case report

01.12.2011 | Original Paper | Sonderheft 1/2011

Feasibility of cetuximab given with a simplified schedule every 2 weeks in advanced colorectal cancer: a multicenter, retrospective analysis

01.12.2011 | Original Paper | Sonderheft 1/2011

Diversity of axin in signaling pathways and its relation to colorectal cancer

01.12.2011 | Original Paper | Sonderheft 1/2011

A relationship between ABO blood groups and clinicopathologic characteristics of patients with gastric adenocarcinoma in China

01.12.2011 | Original Paper | Sonderheft 1/2011

Postoperative chemoradiotherapy in gastric cancer: a phase I study of radiotherapy with dose escalation of oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX regimen)

01.12.2011 | Original Paper | Sonderheft 1/2011

The functional polymorphism in monocyte chemoattractant protein-1 gene increases susceptibility to gastric cancer

01.12.2011 | Original Paper | Sonderheft 1/2011

Hepatic artery chemoembolization for the treatment of liver metastases from neuroendocrine tumors: a long-term follow-up in 123 patients

01.12.2011 | Sonderheft 1/2011

Salvage S-1 monotherapy in metastatic colorectal cancer patients who failed irinotecan-based or oxaliplatin-based chemotherapy

01.12.2011 | Original paper | Sonderheft 1/2011

Evaluation of two modified ECF regimens in the treatment of advanced gallbladder cancer

01.12.2011 | Original Paper | Sonderheft 1/2011

Slug inhibition upregulates radiation-induced PUMA activity leading to apoptosis in cholangiocarcinomas

01.12.2011 | Original Paper | Sonderheft 1/2011

Clinical outcome of panitumumab for metastatic colorectal cancer with wild-type KRAS status: a meta-analysis of randomized clinical trials

01.12.2011 | OriginalPaper | Sonderheft 1/2011

Extracellular matrix protein 1, a novel prognostic factor, is associated with metastatic potential of hepatocellular carcinoma

01.12.2011 | Original Paper | Sonderheft 1/2011

EBV-LMP1-targeted DNAzyme restrains nasopharyngeal carcinoma growth in a mouse C666-1 xenograft model

01.12.2011 | Original Paper | Sonderheft 1/2011

Effect of apoptotic and proliferative indices, P-glycoprotein and survivin expression on prognosis in laryngeal squamous cell carcinoma

01.12.2011 | orignal paper | Sonderheft 1/2011

Identification of candidate molecular markers of nasopharyngeal Carcinoma by tissue microarray and in situ hybridization

01.12.2011 | Original Paper | Sonderheft 1/2011

Inflammatory myofibroblastic tumor of the head and neck

01.12.2011 | Original paper | Sonderheft 1/2011

Analysis of thermochemotherapy-induced apoptosis and the protein expressions of Bcl-2 and Bax in maxillofacial squamous cell carcinomas

01.12.2011 | Original Paper | Sonderheft 1/2011

COX-2 Gene increases tongue cancer cell proliferation and invasion through VEGF-C pathway

01.12.2011 | Sonderheft 1/2011

The clinical study of extranodal natural killer cell lymphoma, nasal type

01.12.2011 | Original Paper | Sonderheft 1/2011

Anti-tumour efficacy of mitofusin-2 in urinary bladder carcinoma

01.12.2011 | Original Paper | Sonderheft 1/2011

RNA interference targeting mutant p53 inhibits growth and induces apoptosis in DU145 human prostate cancer cells

01.12.2011 | Original paper | Sonderheft 1/2011

Primary primitive neuroectodermal tumor of the urinary bladder: a case report and literature review

01.12.2011 | Review Article | Sonderheft 1/2011

Squamous cell carcinoma of the renal pelvis associated with kidney stones: a case report

01.12.2011 | Orginal Paper | Sonderheft 1/2011

Bilateral papilledema on sunitinib therapy for advanced renal cell carcinoma

01.12.2011 | Original Paper | Sonderheft 1/2011

Genetic susceptibility of methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for bladder transitional cell carcinoma in men

01.12.2011 | original paper | Sonderheft 1/2011

Short interfering RNA directed against Slug blocks tumor growth, metastasis formation, and vascular leakage in bladder cancer

01.12.2011 | Review Article | Sonderheft 1/2011

Poor efficacy of BEP polychemotherapy in metastatic spermatocytic seminoma

01.12.2011 | Original paper | Sonderheft 1/2011

Weekly regimen of epirubicin and paclitaxel as second-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II study

01.12.2011 | Original Paper | Sonderheft 1/2011

Expressions of matrix metalloproteinase-7 and matrix metalloproteinase-14 associated with the activation of extracellular signal-regulated kinase1/2 in human brain gliomas of different pathological grades

01.12.2011 | Original Paper | Sonderheft 1/2011

Stereotactic radiosurgery alone for patients with 1–4 radioresistant brain metastases

01.12.2011 | Original paper | Sonderheft 1/2011

Frequency variations in the methylated pattern of p73/p21 genes and chromosomal aberrations correlating with different grades of glioma among south Indian population

01.12.2011 | Original Paper | Sonderheft 1/2011

Antitumor efficacy of a photodynamic therapy-generated dendritic cell glioma vaccine

01.12.2011 | Original Paper | Sonderheft 1/2011

FLANG salvage chemotherapy is an effective regimen that offers a safe bridge to transplantation for patients with relapsed or refractory acute myeloid leukemia

01.12.2011 | Original Paper | Sonderheft 1/2011

Potential role of serum level of soluble CD44 and IFN-γ in B-cell chronic lymphocytic leukemia

01.12.2011 | Original Paper | Sonderheft 1/2011

Clinical characterization and prognostic factors of primary lymphoma of bone in case of Chinese patients

01.12.2011 | Original Paper | Sonderheft 1/2011

Activation of Notch signal pathway is associated with a poorer prognosis in acute myeloid leukemia

01.12.2011 | Review Article | Sonderheft 1/2011

Lymphoma of the breast in a male patient

01.12.2011 | Original Paper | Sonderheft 1/2011

The roles of SDF-1/CXCR4 axis and its relationship with apoptosis in the myelodysplastic syndromes

01.12.2011 | Original Paper | Sonderheft 1/2011

Duplication of Philadelphia chromosome and trisomy of chromosome 21 in a pediatric patient with acute lymphoblastic leukemia

01.12.2011 | Original Paper | Sonderheft 1/2011

Central nervous system involvement in Hodgkin’s lymphoma

01.12.2011 | Original Paper | Sonderheft 1/2011

T(1;21;8)(p34;q22;q22): a novel variant of t(8;21) in acute myeloblastic leukemia with maturation

01.12.2011 | Original Paper | Sonderheft 1/2011

Long-term survey of outcome in acute promyelocytic leukemia: a single center experience in 340 patients

01.12.2011 | original paper | Sonderheft 1/2011

Immunohistochemical evidence for the over-expression of Glutathione peroxidase 3 in clear cell type ovarian adenocarcinoma

01.12.2011 | Original Paper | Sonderheft 1/2011

Down-regulation of HPV18 E6, E7, or VEGF expression attenuates malignant biological behavior of human cervical cancer cells

01.12.2011 | Original Paper | Sonderheft 1/2011

A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results

01.12.2011 | Sonderheft 1/2011

The study of the combination detection of HPV-DNA and p16INK4a in cervical lesions

01.12.2011 | Original Paper | Sonderheft 1/2011

Discrimination analysis of mass spectrometry proteomics for cervical cancer detection

01.12.2011 | Original paper | Sonderheft 1/2011

Induction of lung epithelial cell transformation and fibroblast activation by Yunnan tin mine dust and their interaction

01.12.2011 | Original Paper | Sonderheft 1/2011

Short-term outcomes of cetuximab combined with standard chemotherapy as first line setting for Chinese patients with non-small cell lung cancer: a report of 12 cases

01.12.2011 | Original Paper | Sonderheft 1/2011

Cytoplasmic HuR expression correlates with angiogenesis, lymphangiogenesis, and poor outcome in lung cancer

01.12.2011 | Original Paper | Sonderheft 1/2011

Development of Marjolin’s ulcer within one month of burn injury with synchronous primary lung squamous cell carcinoma in an elderly patient: report of a case with allelotyping

01.12.2011 | Case Report | Sonderheft 1/2011

Primary clear cell adenocarcinoma of the lung

01.12.2011 | Original Paper | Sonderheft 1/2011

Expression and prognostic relevance of MUC1 in stage IB non-small cell lung cancer

01.12.2011 | Original Paper | Sonderheft 1/2011

Third-line therapy for advanced non-small-cell lung cancer patients: feasible drugs for feasible patients

01.12.2011 | Original Paper | Sonderheft 1/2011

Application of support vector machine in cancer diagnosis

01.12.2011 | Original paper | Sonderheft 1/2011

The sequence of drug administration influences the antitumor effects of bevacizumab and cyclophosphamide in a neuroblastoma model

01.12.2011 | Original Paper | Sonderheft 1/2011

Clear cell odontogenic carcinoma: report of 6 cases and review of the literature

01.12.2011 | Review Article | Sonderheft 1/2011

Primary cutaneous small-cell carcinoma: a case report

01.12.2011 | Original Paper | Sonderheft 1/2011

Expression change of ezrin as a prognostic factor in primary osteosarcoma

01.12.2011 | Sonderheft 1/2011

Activity of trabectidin in desmoplastic small round cell tumor

01.12.2011 | Sonderheft 1/2011

Investigation of copy-number variations of C8orf4 in hematological malignancies

01.12.2011 | Original Paper | Sonderheft 1/2011

Inhibition of angiogenic activity of hypoxic fibroblast cell line MRC-5 in vitro by topotecan

01.12.2011 | Original Paper | Sonderheft 1/2011

Immune responses regulation following antitumor dendritic cell-based prophylactic, concurrent, and therapeutic vaccination

01.12.2011 | Original paper | Sonderheft 1/2011

Bladder metastasis of malignant melanoma: a case report and review of literature

01.12.2011 | Original Paper | Sonderheft 1/2011

Value of combined detection of AFU and TCH in differential diagnosis between malignant and non-tuberculous benign ascites

01.12.2011 | Original paper | Sonderheft 1/2011

Biochemical, pathological and oncological relevance of Gb3Cer receptor

01.12.2011 | Original Paper | Sonderheft 1/2011

Treatment of adult patients with Ewing’s sarcoma: compliance with chemotherapy protocols & toxicity

01.12.2011 | Original Paper | Sonderheft 1/2011

Protective effect of l-carnitine versus amifostine against cisplatin-induced nephrotoxicity in rats

01.12.2011 | Original paper | Sonderheft 1/2011

Pegfilgrastim overdose: case report and review of the literature

01.12.2011 | Sonderheft 1/2011

Sunitinib-induced severe hypothyroidism with cardiac compromise

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise